宏柏新材(605366) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥365,709,357.26, representing a decrease of 7.51% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥22,277,468.36, down 72.31% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,038,202.80, a decline of 90.94% compared to the same period last year[5]. - Basic earnings per share for Q3 2023 were ¥0.04, down 69.23% compared to the same period last year[6]. - Total revenue for the first three quarters of 2023 was CNY 1,026,593,644.76, a decrease of 23.8% compared to CNY 1,347,234,921.80 in the same period of 2022[22]. - Operating profit for Q3 2023 was CNY 47,060,979.25, significantly down from CNY 376,505,540.07 in Q3 2022[23]. - Net profit for Q3 2023 was CNY 51,559,762.29, compared to CNY 318,342,593.14 in Q3 2022, reflecting a decline of 83.8%[24]. - Basic and diluted earnings per share for Q3 2023 were both CNY 0.08, down from CNY 0.52 in Q3 2022[25]. Cash Flow and Assets - The cash flow from operating activities for the year-to-date period was ¥147,456,651.18, reflecting a decrease of 54.29% year-on-year[6]. - In the first three quarters of 2023, the net cash flow from operating activities was ¥147,456,651.18, a decrease of 54.4% compared to ¥322,607,402.59 in the same period of 2022[26]. - Total cash inflow from operating activities was ¥941,809,641.42, down 25.7% from ¥1,267,702,553.11 year-on-year[26]. - Cash outflow from operating activities was ¥794,352,990.24, a decrease of 16.0% compared to ¥945,095,150.52 in the previous year[26]. - The ending balance of cash and cash equivalents was ¥339,957,224.04, down from ¥390,446,126.99 at the end of the same period last year[27]. - The total assets at the end of the reporting period were ¥3,110,589,100.14, an increase of 8.16% from the end of the previous year[6]. - As of September 30, 2023, the company's total current assets amounted to RMB 1,199,040,379.41, a decrease from RMB 1,265,418,158.16 at the end of 2022, representing a decline of approximately 5.2%[19]. - Cash and cash equivalents were reported at RMB 339,957,224.04, down from RMB 364,430,933.70 at the end of 2022, indicating a decrease of about 6.7%[19]. - Accounts receivable stood at RMB 338,568,324.98, slightly down from RMB 347,515,148.07, reflecting a decrease of approximately 2.7%[19]. - The company reported inventory of RMB 246,458,857.01, which is slightly down from RMB 247,307,019.08 at the end of 2022, indicating a decrease of about 0.3%[19]. - Long-term receivables were reported at RMB 2,462,085.09, a decrease from RMB 2,725,917.52, reflecting a decline of approximately 9.7%[19]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,757[12]. - The company plans to repurchase shares with a total investment of no less than RMB 10 million and no more than RMB 20 million, representing up to 2% of the total share capital[15]. - The actual controller and chairman, Mr. Ji Jinshu, has increased his shareholding by 1,283,822 shares, accounting for 0.21% of the total share capital[16]. - The actual controller and director, Mr. Lin Qingsong, has increased his shareholding by 1,739,296 shares, representing 0.28% of the total share capital[16]. - The company has not reported any pledged or frozen shares among its major shareholders[14]. Market and Development Strategies - The company reported a decrease in product sales prices, which led to a decline in gross profit margins[10]. - The company is actively pursuing market expansion and new product development strategies, although specific details were not disclosed in the report[15]. Liabilities and Equity - Total liabilities rose to CNY 1,139,592,301.65 in Q3 2023, compared to CNY 868,819,236.99 in Q3 2022, an increase of 31.1%[21]. - The company’s total equity decreased to CNY 1,970,996,798.49 in Q3 2023 from CNY 2,007,152,395.41 in Q3 2022, a decline of 1.8%[21]. Research and Development - Research and development expenses for Q3 2023 were CNY 26,609,797.87, down from CNY 50,310,473.45 in Q3 2022, a decrease of 47.2%[23].